Skip to main content

Advertisement

Log in

A pilot study of neuroprotective effect of granulocyte colony-stimulating factor (G-CSF) in patients with carbon monoxide poisoning: a double-blind, randomized, placebo-controlled trial

  • Research
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Although neuroprotective effects of granulocyte colony-stimulating factor (G-CSF) have been shown in rats exposed to carbon monoxide (CO), this pilot clinical trial was performed to assess the feasibility of treatment with G-CSF in patients with acute CO poisoning. A double-blind, randomized, placebo-controlled pilot clinical trial was conducted on twenty-six patients with acute CO poisoning. G-CSF (90 μg/kg) was administered intravenously for 72 h. Demographic data, routine laboratory tests, differential blood counts, venous blood gas, and adverse reactions were recorded. The primary endpoint was brain ischemia improvement based on CT findings and the secondary endpoints examined improvements in the modified Rankin Scale (mRS), National Institutes of Health Stroke Scale (NIHSS), and Barthel Index as well as S-100β concentrations. Fourteen patients received G-CSF, and 12 received a placebo. Twenty-six were followed for 30 days and no one in both groups died during follow-up. Neurological complications, brain ischemic changes, Barthel, and mRS were compared between the two groups on determined days after the onset of therapeutic intervention, and no significant differences were observed between the two groups. Favorable results were achieved for treated patients by different measures; NIHSS was decreased 72 h after treatment (p = 0.046), and S-100β levels were significantly higher in the G-CSF group than in the control group, 12 h and 72 h after the treatment. G-CSF appears to have potential effects on several clinical parameters in patients with acute CO poisoning. The trial was registered at the Iranian Registry of Clinical Trials with the ID: (IRCT201607232083N7).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References

  • Akdemir HU, Yardan T, Kati C, Duran L, Alacam H, Yavuz Y, Okuyucu A (2014) The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning. Hum Exp Toxicol 33:1113–1120

    Article  CAS  PubMed  Google Scholar 

  • Broderick JP, Adeoye O, Elm J (2017) Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke 48:2007–2012

    Article  PubMed  PubMed Central  Google Scholar 

  • Brvar M, Mozina H, Osredkar J, Mozina M, Noc M, Brucan A, Bunc M (2004) S100B protein in carbon monoxide poisoning: a pilot study. Resuscitation 61:357–360

    Article  CAS  PubMed  Google Scholar 

  • Cakir Z, Aslan S, Umudum Z, Acemoglu H, Akoz A, Turkyilmaz S, Ozturk N (2010) S-100beta and neuron-specific enolase levels in carbon monoxide-related brain injury. Am J Emerg Med 28:61–67

    Article  PubMed  Google Scholar 

  • Chalela JA, Wolf RL, Maldjian JA, Kasner SE (2001) MRI identification of early white matter injury in anoxic-ischemic encephalopathy. Neurology 56:481–485

    Article  CAS  PubMed  Google Scholar 

  • Cioncoloni D, Piu P, Tassi R, Acampa M, Guideri F, Taddei S, Bielli S, Martini G, Mazzocchio R (2012) Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke. NeuroRehabilitation 30:315–322

    Article  CAS  PubMed  Google Scholar 

  • Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019–2026

    Article  CAS  PubMed  Google Scholar 

  • Davoudi Y, Dadpour B, Afshari R, Hasaniyeh N, Matin N, Rahimi-Doab MJAPJOMT (2014) Structural Findings in the Brain MRI of Patients with Acute Carbon Monoxide Poisoning 3:124–129

    Google Scholar 

  • Duelsner A, Gatzke N, Glaser J, Hillmeister P, Li M, Lee EJ, Lehmann K, Urban D, Meyborg H, Stawowy P, Busjahn A, Nagorka S, Persson AB, Laage R, Schneider A, Buschmann IR (2012) Granulocyte colony-stimulating factor improves cerebrovascular reserve capacity by enhancing collateral growth in the circle of Willis. Cerebrovasc Dis 33:419–429

    Article  CAS  PubMed  Google Scholar 

  • Duvallet A, Borne M, Rouquette I, Brinquin L (2007) Serum S100β protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in carbon monoxide poisoning? Fed Am Soc Exp Biol

  • England TJ, Sprigg N, Alasheev AM, Belkin AA, Kumar A, Prasad K, Bath PM (2016) Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis. Sci Rep 6:36567

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fan ZZ, Cai HB, Ge ZM, Wang LQ, Zhang XD, Li L, Zhai XB (2015) The Efficacy and Safety of Granulocyte Colony-Stimulating Factor for Patients with Stroke. J Stroke Cerebrovasc Dis 24:1701–1708

    Article  PubMed  Google Scholar 

  • Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism Jama 282:2003–2011

    CAS  PubMed  Google Scholar 

  • Gale SD, Hopkins RO, Weaver LK, Bigler ED, Booth EJ, Blatter DD (1999) MRI, quantitative MRI, SPECT, and neuropsychological findings following carbon monoxide poisoning. Brain Inj 13:229–243

    Article  CAS  PubMed  Google Scholar 

  • Ghorbani M, Moallem S, Abnous K, Tabatabaee Yazdi SA, Movassaghi AR, Azizzadeh M, Mohamadpour AH (2013) The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats. Drug Chem Toxicol 36:102–108

    Article  CAS  PubMed  Google Scholar 

  • Gozubuyuk AA, Dag H, Kacar A, Karakurt Y, Arica V (2017) Epidemiology, pathophysiology, clinical evaluation, and treatment of carbon monoxide poisoning in child, infant, and fetus. North Clin Istanb 4:100–107

    PubMed  PubMed Central  Google Scholar 

  • Guan L, Wen T, Zhang Y, Wang X, Zhao J (2009) Induction of heme oxygenase-1 with hemin attenuates hippocampal injury in rats after acute carbon monoxide poisoning. Toxicology 262:146–152

    Article  CAS  PubMed  Google Scholar 

  • Hampson NB, Dunford RG, Ross DE, Wreford-Brown CE (2006) A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea Hyperb Med 33:27–32

    CAS  PubMed  Google Scholar 

  • Hashemzaei M, Imen Shahidi M, Moallem SA, Abnous K, Ghorbani M, Mohamadpour AH (2016) Modulation of JAK2, STAT3 and Akt1 proteins by granulocyte colony stimulating factor following carbon monoxide poisoning in male rat. Drug Chem Toxicol 39:375–379

    Article  CAS  PubMed  Google Scholar 

  • Huang X, Liu Y, Bai S, Peng L, Zhang B, Lu H (2017) Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial. PLoS ONE 12:e0175774

    Article  PubMed  PubMed Central  Google Scholar 

  • Ide T, Kamijo Y, Ide A, Yoshimura K, Nishikawa T, Soma K, Mochizuki H (2012) Elevated S100B level in cerebrospinal fluid could predict poor outcome of carbon monoxide poisoning. Am J Emerg Med 30:222–225

    Article  PubMed  Google Scholar 

  • Iwanaga K, Takano H, Ohtsuka M, Hasegawa H, Zou Y, Qin Y, Odaka K, Hiroshima K, Tadokoro H, Komuro I (2004) Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 325:1353–1359

    Article  CAS  PubMed  Google Scholar 

  • Jones JS, Lagasse J, Zimmerman G (1994) Computed tomographic findings after acute carbon monoxide poisoning. Am J Emerg Med 12:448–451

    Article  CAS  PubMed  Google Scholar 

  • Jung KH, Chu K, Lee ST, Kang L, Kim SU, Kim M, Roh JK (2006) G-CSF protects human cerebral hybrid neurons against in vitro ischemia. Neurosci Lett 394:168–173

    Article  CAS  PubMed  Google Scholar 

  • Kim KS, Weinberg PE, Suh JH, Ho SU (1980) Acute carbon monoxide poisoning: computed tomography of the brain. AJNR Am J Neuroradiol 1:399–402

    PubMed Central  Google Scholar 

  • Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, Osaka A, Mochizuki H, Mizuno Y, Urabe T (2006) Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26:402–413

    Article  CAS  PubMed  Google Scholar 

  • Lee ST, Chu K, Jung KH, Ko SY, Kim EH, Sinn DI, Lee YS, Lo EH, Kim M, Roh JK (2005) Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058:120–128

    Article  CAS  PubMed  Google Scholar 

  • Lim PJ, Shikhare SN, Peh WC (2014) Clinics in diagnostic imaging (154). Carbon monoxide (CO) poisoning. Singapore Med J55:405–409; quiz 410

  • Liu DF, Zhao B, Lu YL, Yao XR, Liao J (2013) Observation on therapeutic effect of acupuncture intervention combined with hyperbaric oxygen therapy for delayed encephalopathy caused by carbon monoxide poisoning. Zhen Ci Yan Jiu 38:407–410

    PubMed  Google Scholar 

  • Lu CZ, Xiao BG (2006) G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia. Biochem Soc Trans 34:1327–1333

    Article  CAS  PubMed  Google Scholar 

  • McCollum M, Ma Z, Cohen E, Leon R, Tao R, Wu JY, Maharaj D, Wei J (2010) Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson’s disease. Mol Neurobiol 41:410–419

    Article  CAS  PubMed  Google Scholar 

  • Miura T, Mitomo M, Kawai R, Harada K (1985) CT of the brain in acute carbon monoxide intoxication: characteristic features and prognosis. AJNR Am J Neuroradiol 6:739–742

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mizuma A, Yamashita T, Kono S, Nakayama T, Baba Y, Itoh S, Asakura K, Niimi Y, Asahi T, Kanemaru K, Mutoh T, Kuroda S, Kinouchi H, Abe K, Takizawa S (2016) Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis 25:1451–1457

    Article  PubMed  Google Scholar 

  • O’Donnell P, Buxton PJ, Pitkin A, Jarvis LJ (2000) The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning. Clin Radiol 55:273–280

    Article  PubMed  Google Scholar 

  • Okeda R, Funata N, Takano T, Miyazaki Y, Higashino F, Yokoyama K, Manabe M (1981) The pathogenesis of carbon monoxide encephalopathy in the acute phase–physiological and morphological correlation. Acta Neuropathol 54:1–10

    Article  CAS  PubMed  Google Scholar 

  • Ozcan N, Ozcam G, Kosar P, Ozcan A, Basar H, Kaymak C (2016) Correlation of computed tomography, magnetic resonance imaging and clinical outcome in acute carbon monoxide poisoning. Braz J Anesthesiol 66:529–532

    Article  PubMed  Google Scholar 

  • Pang L, Bian M, Zang XX, Wu Y, Xu DH, Dong N, Wang ZH, Yan BL, Wang DW, Zhao HJ, Zhang N (2013) Neuroprotective effects of erythropoietin in patients with carbon monoxide poisoning. J Biochem Mol Toxicol 27:266–271

    Article  CAS  PubMed  Google Scholar 

  • Park E, Ahn J, Min YG, Jung YS, Kim K, Lee J, Choi SC (2012) The usefulness of the serum s100b protein for predicting delayed neurological sequelae in acute carbon monoxide poisoning. Clin Toxicol (phila) 50:183–188

    Article  CAS  PubMed  Google Scholar 

  • Pearson M (2000) Measuring clinical outcome in stroke (acute care). R Coll Phys

  • Prockop LD, Chichkova RI (2007) Carbon monoxide intoxication: an updated review. J Neurol Sci 262:122–130

    Article  CAS  PubMed  Google Scholar 

  • Quinn TJ, Langhorne P, Stott DJ (2011) Barthel index for stroke trials: development, properties, and application. Stroke 42:1146–1151

    Article  PubMed  Google Scholar 

  • Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charisse G, Fiebach JB, Schwab S, Schäbitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Köhrmann M, Berrouschot J (2013) Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke 44:2681–2687

    Article  CAS  PubMed  Google Scholar 

  • Roth D, Schreiber W, Herkner H, Havel C (2014) Prevalence of carbon monoxide poisoning in patients presenting to a large emergency department. Int J Clin Pract 68:1239–1245

    Article  CAS  PubMed  Google Scholar 

  • Schabitz W-R, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke M, Sommer C, Schwab S (2003) Neuroprotective effect of granulocyte colony–stimulating factor after focal cerebral Ischemia. Stroke 34:745–751

    Article  PubMed  Google Scholar 

  • Schabitz W-R, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke M, Sommer C, Schwab S (2003) Neuroprotective effect of granulocyte colony–stimulating factor after focal cerebral Ischemia. Stroke 34:745–751

    Article  PubMed  Google Scholar 

  • Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R (2010) AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 41:2545–2551

    Article  PubMed  Google Scholar 

  • Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A (2010) AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 41:2545–2551

    Article  PubMed  Google Scholar 

  • Schäbitz WR, Schneider A (2007) New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol Sci 28:157–161

    Article  PubMed  Google Scholar 

  • Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W (2005a) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Investig 115:2083–2098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115:2083–2098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider A, Kuhn HG, Schäbitz WR (2005c) A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4:1753–1757

    Article  CAS  PubMed  Google Scholar 

  • Schneider A, Wysocki R, Pitzer C, Kruger C, Laage R, Schwab S, Bach A, Schäbitz WR (2006) An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol 4:36

    Article  PubMed  PubMed Central  Google Scholar 

  • Sener RN (2003) Acute carbon monoxide poisoning: diffusion MR imaging findings. AJNR Am J Neuroradiol 24:1475–1477

    PubMed  PubMed Central  Google Scholar 

  • Shyu W-C, Lin S-Z, Lee C-C, Liu DD, Li H (2006) Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174:927–933

    Article  PubMed  PubMed Central  Google Scholar 

  • Six I, Gasan G, Mura E, Bordet R (2003) Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 458:327–328

    Article  CAS  PubMed  Google Scholar 

  • Spina V, Tomaiuolo F, Celli L, Bonfiglio L, Cecchetti L, Carboncini MC (2019) A Case of Carbon Monoxide-Induced Delayed Neurological Sequelae Successfully Treated with Hyperbaric Oxygen Therapy, N-Acetylcysteine, and Glucocorticoids: Clinical and Neuroimaging Follow-Up. Case Rep Neurol Med 2019:9360542

    PubMed  PubMed Central  Google Scholar 

  • Sulter G, Steen C, de Keyser J (1999) Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30:1538–1541

    Article  CAS  PubMed  Google Scholar 

  • Thom SR, Bhopale VM, Fisher D, Zhang J, Gimotty P (2004) Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci U S A 101:13660–13665

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vieregge P, Klostermann W, Blumm RG, Borgis KJ (1989) Carbon monoxide poisoning: clinical, neurophysiological, and brain imaging observations in acute disease and follow-up. J Neurol 236:478–481

    Article  CAS  PubMed  Google Scholar 

  • Wang P, Zeng T, Zhang CL, Gao XC, Liu Z, Xie KQ, Chi ZF (2009) Lipid peroxidation was involved in the memory impairment of carbon monoxide-induced delayed neuron damage. Neurochem Res 34:1293–1298

    Article  CAS  PubMed  Google Scholar 

  • Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W (1993) Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981–1984

    Article  CAS  PubMed  Google Scholar 

  • Weaver LK (2009) Clinical practice. Carbon monoxide poisoning. N Engl J Med 360:1217–1225

    Article  CAS  PubMed  Google Scholar 

  • Wolf SJ, Maloney GE, Shih RD, Shy BD, Brown MD (2017) Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Carbon Monoxide Poisoning. Ann Emerg Med 69:98-107.e6

    Article  PubMed  Google Scholar 

  • Yardan T, Cevik Y, Donderici O, Kavalci C, Yilmaz FM, Yilmaz G, Vural K, Yuzbasioglu Y, Gunaydin YK, Sezer AA (2009) Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning. Am J Emerg Med 27:838–842

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Mashhad University of Medical Sciences for financial supports under grant number: 950789.

Funding

This work was supported by the Mashhad University of Medical Sciences under grant number: 950789.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. SRM and AHM conceived and designed research. MM and JF conducted experiments. SRM and AP wrote the manuscript. SS revised it critically and finally approved the version to be submitted. All authors reviewed, considered, and approved the manuscript.

Corresponding authors

Correspondence to Atena Pourtaji or Sara Samadi.

Ethics declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Mashhad University of Medical Sciences (February 25, 2017/No. IR.MUMS.SP.1395.73).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mousavi, S.R., Mohammadpour, A.H., Moshiri, M. et al. A pilot study of neuroprotective effect of granulocyte colony-stimulating factor (G-CSF) in patients with carbon monoxide poisoning: a double-blind, randomized, placebo-controlled trial. Naunyn-Schmiedeberg's Arch Pharmacol 396, 1257–1267 (2023). https://doi.org/10.1007/s00210-023-02395-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-023-02395-8

Keywords

Navigation